These findings have direct clinical significance because although the majority of inv(16) AML cases include HABD sequence in the CBFB-MYH11 transcripts, fraction of cases lack HABD sequence due to a different breakpoint on the MYH11 part of inv(16). This evidence concerns the gene MYH11 and acute myeloid leukemia.